SLC6A12
MOLECULAR TARGETsolute carrier family 6 member 12
SLC6A12 (solute carrier family 6 member 12) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SLC6A12
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gamma-Aminobutyric Acid | 3.71 | 40 |
| 2 | Tiagabine | 1.10 | 2 |
About SLC6A12 as a Drug Target
SLC6A12 (solute carrier family 6 member 12) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented SLC6A12 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SLC6A12 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.